Nature communications · 2026
Discovery of 5' NAD capped viral RNAs reveals evolutionary divergent 5' metabolite capping across hepaciviruses.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Larsen Helena S, Sherwood Anna V, Rivera-Rangel Lizandro R, Ryberg Line A, Faller Paula H, Thorselius Caroline E, Vågbø Cathrine B, Holmbeck Kenn, Fernbach Sonja, Chubanava Sabina, Hassing Anna S, Jakljevič Eva, Rose Nicola, Tjørnelund-Sjursen Helena D, Wolfisberg Raphael, Kennedy Matthew J, Nielsen Louise, Al-Chaer Amal, Ramirez Santseharay, Treebak Jonas T, Bukh Jens, Vinther Jeppe, Scheel Troels K H
Аннотация
Hepatitis C virus (HCV), an important pathogen and prototype hepacivirus, 5' caps its RNA with flavin adenine dinucleotide (FAD); no other 5' metabolite capped viral RNAs have been identified. Here, we establish NADzymeID, allowing specific identification of 5' nicotinamide adenine dinucleotide (NAD). Using NADzymeID, we find that Norway rat hepacivirus 1 (NrHV-1) and related hepaciviruses use 5' NAD capping, whereas the closest relatives of HCV use 5' FAD, thereby revealing evolutionary divergence of 5' capping. NrHV-1 replication is attenuated in absence of NAD, and NrHV-1 is cleared more rapidly in mice with reduced intrahepatic NAD levels. As observed for 5' FAD, 5' NAD protects viral RNA from RIG-I mediated innate immune sensing. Thus, despite evolutionary divergence, metabolite capping generally confers evasion of innate immune responses. These represent the first examples of 5' NAD capping for viruses, providing tools also to investigate the elusive function of cellular 5' metabolite caps.